3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
2
Unknown
1
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Vulvar Neoplasms
2
Ovarian Neoplasms
2
Brain Neoplasms
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Soft Tissue Neoplasms
1
Skull Base Neoplasms
1
Gastric Adenocarcinoma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Bone Neoplasms
1
Anastomotic Leak
1
Interventions
Cisplatin
7
Paclitaxel
5
Radiotherapy
4
Platinum
3
zimberelimab
2
pembrolizumab
2
nimotuzumab
2
lenvatinib
2
Taxes
2
Injections
2
Human Papillomavirus Recombinant Vaccine nonavalent
2
Carboplatin
2
Brachytherapy
2
trilaciclib
1
toripalimab
1
tislelizumab
1
sintilimab
1
neratinib
1
fludarabine
1
envafolimab
1
camrelizumab
1
Watchful Waiting
1
Ultrasonography, Doppler
1
Transurethral Resection of Prostate
1
Therapeutics
1
Telemedicine
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Specimen Handling
1
Sensitivity Training Groups
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Uterine Cervical Neoplasms
×
Indocyanine Green
×
Clear all
NCT06871787
2025-03-14
INOCA
Istanbul University
Phase 4
Not yet recruiting
50 enrolled